Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 3,962 | 6,692 | 9,733 | 9,248 | 8,635 |
| Cost of Goods | 2,236 | 3,042 | 4,656 | 9,075 | 5,138 |
| Gross Profit | 1,726 | 3,650 | 5,078 | 173 | 3,497 |
| Operating Expenses | 3,390 | 3,426 | 4,313 | 2,598 | 3,229 |
| Operating Income | -1,428 | 265 | 1,420 | -2,350 | 406 |
| Interest Expense | 120 | 70 | 89 | 87 | 83 |
| Other Income | 12 | 13 | 1 | -3,041 | 27 |
| Pre-tax Income | -1,536 | 209 | 1,332 | -5,478 | 350 |
| Income Tax | -297 | 82 | 355 | -1,525 | 359 |
| Net Income Continuous | -1,239 | 126 | 978 | -3,952 | -9 |
| Minority Interests | 2 | N/A | -8 | -11 | -46 |
| Net Income | $-1,241 | $126 | $986 | $-3,941 | $38 |
| EPS Basic Total Ops | -0.04 | 0.00 | 0.03 | -0.14 | 0.00 |
| EPS Basic Continuous Ops | -0.04 | 0.00 | 0.03 | -0.13 | 0.00 |
| EPS Diluted Total Ops | -0.04 | 0.00 | 0.03 | -0.14 | 0.00 |
| EPS Diluted Continuous Ops | -0.04 | 0.00 | 0.03 | -0.13 | 0.00 |
| EBITDA(a) | $1,853 | $907 | $2,064 | $-1,708 | $1,055 |